Placebo to glipizide

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Renal InsufficiencyDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 3

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

CompletedNCT00095056

Merck Sharp & Dohme LLCChronic Renal Insufficiency, Diabetes Mellitus, Type 2

Start: 2004-10-31End: 2006-07-31Updated: 2015-04-02

A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

CompletedNCT01698775

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2012-10-02End: 2016-01-19Updated: 2018-08-09

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01